72 related articles for article (PubMed ID: 3110477)
1. Modulation of cell proliferation by human recombinant interleukin-1 and immune interferon.
Tsai SC; Gaffney EV
J Natl Cancer Inst; 1987 Jul; 79(1):77-81. PubMed ID: 3110477
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1.
Morikawa K; Fidler IJ
J Biol Response Mod; 1989 Apr; 8(2):206-18. PubMed ID: 2499665
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition of a human colorectal carcinoma cell line by interleukin 1 is associated with enhanced expression of gamma-interferon receptors.
Raitano AB; Korc M
Cancer Res; 1993 Feb; 53(3):636-40. PubMed ID: 8425199
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte-activating and growth-inhibitory activities for several sources of native and recombinant interleukin 1.
Gaffney EV; Tsai SC
Cancer Res; 1986 Aug; 46(8):3834-7. PubMed ID: 3488121
[TBL] [Abstract][Full Text] [Related]
5. Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression.
Gastl G; Marth C; Leiter E; Gattringer C; Mayer I; Daxenbichler G; Flener R; Huber C
Cancer Res; 1985 Jul; 45(7):2957-61. PubMed ID: 3924395
[TBL] [Abstract][Full Text] [Related]
6. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
[TBL] [Abstract][Full Text] [Related]
7. Overlapping polypeptide induction in human fibroblasts in response to treatment with interferon-alpha, interferon-gamma, interleukin 1 alpha, interleukin 1 beta, and tumor necrosis factor.
Beresini MH; Lempert MJ; Epstein LB
J Immunol; 1988 Jan; 140(2):485-93. PubMed ID: 3121746
[TBL] [Abstract][Full Text] [Related]
8. Human interleukin 1 is a cytocidal factor for several tumor cell lines.
Onozaki K; Matsushima K; Aggarwal BB; Oppenheim JJ
J Immunol; 1985 Dec; 135(6):3962-8. PubMed ID: 2415593
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta 1 inhibits interleukin-1-induced but enhances ionomycin-induced interferon-gamma production in a T cell lymphoma: comparison with the effects of rapamycin.
Dumont FJ; Kastner CA
J Cell Physiol; 1994 Jul; 160(1):141-53. PubMed ID: 8021294
[TBL] [Abstract][Full Text] [Related]
10. The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells.
Gooch JL; Herrera RE; Yee D
Cell Growth Differ; 2000 Jun; 11(6):335-42. PubMed ID: 10910100
[TBL] [Abstract][Full Text] [Related]
11. Differential gamma-interferon response of human colon carcinoma cells: inhibition of proliferation and modulation of immunogenicity as independent effects of gamma-interferon on tumor cell growth.
Pfizenmaier K; Bartsch H; Scheurich P; Seliger B; Ucer U; Vehmeyer K; Nagel GA
Cancer Res; 1985 Aug; 45(8):3503-9. PubMed ID: 3160456
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
Liu L; Gudas LJ
J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002
[TBL] [Abstract][Full Text] [Related]
13. Induction of hepatocyte growth factor/scatter factor by interferon-gamma in human leukemia cells.
Gohda E; Takebe T; Sotani T; Nakamura S; Minowada J; Yamamoto I
J Cell Physiol; 1998 Jan; 174(1):107-14. PubMed ID: 9397161
[TBL] [Abstract][Full Text] [Related]
14. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of hepatocyte growth factor induction in human dermal fibroblasts by interleukin-1 and its prevention by interferon-gamma.
Takami Y; Kanasaki K; Tsubouchi H; Ishii T; Yamamoto I; Gohda E
Biochem Biophys Res Commun; 2004 Dec; 325(3):676-82. PubMed ID: 15541342
[TBL] [Abstract][Full Text] [Related]
16. Correlation between human cell growth response to interleukin 1 and receptor binding.
Gaffney EV; Koch G; Tsai SC; Loucks T; Lingenfelter SE
Cancer Res; 1988 Oct; 48(19):5455-9. PubMed ID: 2970890
[TBL] [Abstract][Full Text] [Related]
17. Antitumor actions of interferon-gamma and interleukin-1 beta on human papillary thyroid carcinoma cell lines.
Yip I; Pang XP; Berg L; Hershman JM
J Clin Endocrinol Metab; 1995 May; 80(5):1664-9. PubMed ID: 7745015
[TBL] [Abstract][Full Text] [Related]
18. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor.
Le JM; Vilcek J
J Immunol; 1987 Nov; 139(10):3330-7. PubMed ID: 3119705
[TBL] [Abstract][Full Text] [Related]
19. Regrowth of 5-fluorouracil-treated human colon cancer cells is prevented by the combination of interferon gamma, indomethacin, and phenylbutyrate.
Huang Y; Horvath CM; Waxman S
Cancer Res; 2000 Jun; 60(12):3200-6. PubMed ID: 10866311
[TBL] [Abstract][Full Text] [Related]
20. Synergistic antiproliferative effect of human recombinant interferons and retinoic acid in cultured breast cancer cells.
Marth C; Daxenbichler G; Dapunt O
J Natl Cancer Inst; 1986 Dec; 77(6):1197-202. PubMed ID: 3099046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
